Provided by Tiger Trade Technology Pte. Ltd.

Liminatus Pharma LLC

3.75
+0.02000.54%
Post-market: 3.750.00000.00%19:30 EDT
Volume:28.17K
Turnover:105.34K
Market Cap:5.04M
PE:-0.21
High:3.86
Open:3.74
Low:3.65
Close:3.73
52wk High:141.50
52wk Low:3.29
Shares:1.34M
Float Shares:581.43K
Volume Ratio:1.38
T/O Rate:4.85%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-18.0650
EPS(LYR):-21.4999
ROE:--
ROA:-95.65%
PB:16.76
PE(LYR):-0.17

Loading ...

Liminatus Pharma regains compliance with Nasdsaq min bid price rule

TIPRANKS
·
Sep 29

Liminatus Pharma Regains NASDAQ Minimum Bid Price Compliance After Reverse Stock Split

Reuters
·
Sep 29

Liminatus Pharma Regains Compliance with NASDAQ Minimum Bid Price Rule

THOMSON REUTERS
·
Sep 29

Liminatus Pharma Taps Synex as CRO for Ibc101 Phase 1/2a Study in South Korea

Reuters
·
Aug 24

Liminatus Pharma Engages Synex as Contract Research Organization to Support Phase 1/2a Clinical Development of Cd19xcd22 Bivalent CAR-T Therapy

THOMSON REUTERS
·
Aug 24

Liminatus Pharma Reports Reverse Stock Split

MT Newswires Live
·
Aug 19

Liminatus Pharma Sets 1-for-50 Reverse Stock Split Effective Aug. 20

Reuters
·
Aug 19

Liminatus Pharma, Inc. Announces Reverse Stock Split of Its Common Stock

THOMSON REUTERS
·
Aug 19

Liminatus Pharma - Announces 1-for-50 Reverse Stock Split

THOMSON REUTERS
·
Aug 19

Liminatus Pharma Q2 FY26 Net Loss Widens to $1.41 Million; Operating Loss Widens 23% to $1.38 Million

Reuters
·
Aug 15

Liminatus Pharma (LIMN) Stock Jumps Over 50% on a Listing Update

TIPRANKS
·
Aug 14

Liminatus Pharma Announces Transfer to NASDAQ Capital Market and Extension to Regain Compliance with Minimum Bid Price Requirement

THOMSON REUTERS
·
Aug 13

Liminatus Pharma Moves NASDAQ Listing to Capital Market Tier

Reuters
·
Aug 13

Liminatus Pharma Annual Meeting Draws 48.31% of Shares Represented

Reuters
·
Aug 05

Liminatus Pharma Awaits NASDAQ Ruling After Saying Equity Tops $2.5 Million Threshold

Reuters
·
Jul 30

Liminatus Pharma Faces Potential NASDAQ Delisting After Failing $1 Minimum Bid Price Rule

Reuters
·
Jul 25

Liminatus Pharma Discloses Ewon Comfortech Initial Beneficial Ownership of 5.5 Million Shares

Reuters
·
Jul 07

Liminatus Pharma Amends Innocsai Merger Terms to Use Non-voting Convertible Preferred Stock

Reuters
·
Jul 06

NASD Most Active Issues

Dow Jones
·
Jul 03

Top Premarket Gainers

MT Newswires Live
·
Jul 02